Free Trial
NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

TRxADE HEALTH logo
$1.12 -0.06 (-5.08%)
As of 08/19/2025

About TRxADE HEALTH Stock (NASDAQ:MEDS)

Key Stats

Today's Range
$1.10
$1.24
50-Day Range
$0.90
$2.39
52-Week Range
$3.69
$44.56
Volume
439,319 shs
Average Volume
207,831 shs
Market Capitalization
$1.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

MEDS Stock News Headlines

TRxADE HEALTH (NASDAQ:MEDS) Shares Down 2.5% - Here's Why
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
TRxADE Health (NASDAQ: MEDS)
Scienture Holdings, Inc. (SCNX)
See More Headlines

MEDS Stock Analysis - Frequently Asked Questions

TRxADE HEALTH's stock was trading at $6.20 at the beginning of 2025. Since then, MEDS stock has decreased by 81.9% and is now trading at $1.12.

TRxADE HEALTH, Inc. (NASDAQ:MEDS) announced its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The firm had revenue of $2.55 million for the quarter, compared to the consensus estimate of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 196.79% and a negative net margin of 149.81%.

Shares of TRxADE HEALTH reverse split before market open on Thursday, June 22nd 2023.The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include NVIDIA (NVDA), Communications Systems (JCS), Biora Therapeutics (BIOR), Paratek Pharmaceuticals (PRTK), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
10/24/2021
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Wholesale
Current Symbol
NASDAQ:MEDS
CIK
1382574
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.84 million
Net Margins
-149.81%
Pretax Margin
-250.53%
Return on Equity
-196.79%
Return on Assets
-112.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.18
Quick Ratio
4.18

Sales & Book Value

Annual Sales
$7.45 million
Price / Sales
0.21
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
2.49

Miscellaneous

Outstanding Shares
1,406,000
Free Float
725,000
Market Cap
$1.57 million
Optionable
Not Optionable
Beta
2.32

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MEDS) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners